PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury

PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury

Phenylacetylglutamine (PAGln), a gut microbiota (GM)-derived metabolite, is associated with cardiovascular disease. Studies have shown that disordered GM participated in the progression of atrial fibrillation (AF), but the relationship between PAGln and AF is unclear. This study investigated the cha...

Full description

Bibliographic Details
Main Authors: Chen Fang, Kun Zuo, Kaicheng Jiao, Xiaoming Zhu, Yuan Fu, Jiuchang Zhong, Li Xu, Xinchun Yang
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomolecules
Subjects:
atrial fibrillation
phenylacetylglutamine
atrial myocytes
apoptosis
ROS
Online Access:https://www.mdpi.com/2218-273X/12/8/1120

Internet

https://www.mdpi.com/2218-273X/12/8/1120

Similar Items